BioMarin Pharmaceutical Inc. at Canaccord Genuity Growth Conference Transcript
All right. Good morning, everyone. Thank you so much for joining us. My name is Whitney Ijem. I am one of the biotech analysts here at Canaccord. And it's my pleasure to introduce BioMarin Pharmaceuticals this morning. And on behalf of BioMarin, we have Brian Mueller, CFO. Thank you for being here.
Questions & Answers
So just to start off high level for anybody who's not familiar, for anybody who that might be, I don't know, BioMarin is a household name. But for anybody who is not familiar, can you briefly introduce the story, like who is BioMarin currently? And where are you trying to go over the next 5-, 10 years?
Yes. Thanks, Whitney, for having us. Really glad to be here. Thanks, everyone, joining in person and those online. Yes. So I do think there are some folks that may not be familiar with BioMarin
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
